Higher protein, low glycemic load diet for Metabolic Syndrome

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Arkansas, Fayetteville, ARMetabolic SyndromeHigher protein, low glycemic load diet - DietarySupplement
Eligibility
18 - 85
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test if regular potato consumption can improve cardiometabolic health in individuals with MetS.

Eligible Conditions
  • Metabolic Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 7 Secondary · Reporting Duration: Change from baseline at 16 weeks

Week 16
Appetite
Marker of appetite and sleep
Mood
Plasma glucose levels
Serum lipid levels
Sleep duration
Sleep quality and duration
Waist circumference
Week 16
Dietary intake

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Higher Protein, Low Glycemic Load with Processed Potatoes
1 of 3
Higher Protein, Low Glycemic Load with Potatoes
1 of 3
Higher Protein, Low Glycemic Load - Control
1 of 3

Active Control

Experimental Treatment

Non-Treatment Group

90 Total Participants · 3 Treatment Groups

Primary Treatment: Higher protein, low glycemic load diet · Has Placebo Group · N/A

Higher Protein, Low Glycemic Load with Potatoes
DietarySupplement
Experimental Group · 1 Intervention: Higher protein, low glycemic load diet · Intervention Types: DietarySupplement
Higher Protein, Low Glycemic Load - Control
DietarySupplement
PlaceboComparator Group · 1 Intervention: Higher protein, low glycemic load diet · Intervention Types: DietarySupplement
Higher Protein, Low Glycemic Load with Processed Potatoes
DietarySupplement
ActiveComparator Group · 1 Intervention: Higher protein, low glycemic load diet · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change from baseline at 16 weeks

Who is running the clinical trial?

University of Arkansas, FayettevilleLead Sponsor
19 Previous Clinical Trials
1,595 Total Patients Enrolled

Eligibility Criteria

Age 18 - 85 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You live in Northwest Arkansas.
People of all races and ethnicities are eligible.
The study is open to both males and females.
You are currently eating a lot of foods that raise your blood sugar quickly.

Frequently Asked Questions

What is the total number of participants involved in this medical experiment?

"Correct. By consulting clinicaltrials.gov, it is visible that this medical experiment has been in search of participants since June 1st 2019 and was recently updated on June 16th 2021. This trial requires 90 individuals to be recruited from a single healthcare centre." - Anonymous Online Contributor

Unverified Answer

To which demographics is enrollment for this clinical trial accessible?

"This clinical research is accepting 90 members, aged between 18 and 85 that have metabolic syndrome. To be eligible for the trial, participants must meet certain conditions: living in Northwest Arkansas, being of any ethnicity or gender, and consuming a high glycemic load diet." - Anonymous Online Contributor

Unverified Answer

What aims does this investigation seek to achieve?

"This 16-week experiment evaluates serum lipid levels as its primary outcome. Secondary data points include sleep duration (measured by an Actigraph), dietary intake (via monthly food records), and a Pittsburgh Sleep Quality Index to assess overall quality of rest." - Anonymous Online Contributor

Unverified Answer

Are there any opportunities for people to partake in this research?

"Affirmative. As per the information stored on clinicaltrials.gov, this medical trial is currently signing up participants and was originally publicised on June 1st 2019. 90 test subjects are expected to be enrolled from one health facility before its most recent update of 16th June 2021." - Anonymous Online Contributor

Unverified Answer

Is the age restriction to participate in this trial exceeding 55 years?

"The requirements for this trial stipulate that individuals should be between 18 and 85 years of age in order to qualify." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.